These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1794867)

  • 21. Mode of action of miconazole on Candida albicans: effect on growth, viability and K+ release.
    Cope JE
    J Gen Microbiol; 1980 Jul; 119(1):245-51. PubMed ID: 6997434
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro synergic antifungal effect of MUC7 12-mer with histatin-5 12-mer or miconazole.
    Wei GX; Bobek LA
    J Antimicrob Chemother; 2004 May; 53(5):750-8. PubMed ID: 15073161
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Further studies on factors controlling phenotypic susceptibility of Candida albicans to miconazole kill.
    Beggs WH
    Res Commun Chem Pathol Pharmacol; 1990 Jan; 67(1):159-62. PubMed ID: 2183320
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Susceptibility of Candida albicans biofilms grown in a constant depth film fermentor to chlorhexidine, fluconazole and miconazole: a longitudinal study.
    Lamfon H; Porter SR; McCullough M; Pratten J
    J Antimicrob Chemother; 2004 Feb; 53(2):383-5. PubMed ID: 14729749
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipid-covered drug particles: combined action of dioctadecyldimethylammonium bromide and amphotericin B or miconazole.
    Lincopan N; Carmona-Ribeiro AM
    J Antimicrob Chemother; 2006 Jul; 58(1):66-75. PubMed ID: 16636081
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disappearance of nystatin resistance in Candida mediated by ergosterol.
    Mas J; Piña E
    J Gen Microbiol; 1980 Mar; 117(1):249-52. PubMed ID: 6993624
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro activity of fluconazole on Candida albicans.
    Abecia LC; Arévalo JM; López MJ
    Microbiologia; 1996 Dec; 12(4):613-20. PubMed ID: 9018696
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Candida resistant to nystatin becomes sensitive upon culture with ergosterol.
    Mas J; Piña E
    Arch Invest Med (Mex); 1985; 16(2):145-55. PubMed ID: 3907567
    [No Abstract]   [Full Text] [Related]  

  • 29. The effect of altered ergosterol content on the transport of various amino acids in Candida albicans.
    Singh M; Jayakumar A; Prasad R
    Biochim Biophys Acta; 1979 Jul; 555(1):42-55. PubMed ID: 383149
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Membrane raft lipid constituents affect drug susceptibilities of Candida albicans.
    Pasrija R; Prasad T; Prasad R
    Biochem Soc Trans; 2005 Nov; 33(Pt 5):1219-23. PubMed ID: 16246085
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antifolates as antimycotics? Connection between the folic acid cycle and the ergosterol biosynthesis pathway in Candida albicans.
    Navarro-Martínez MD; Cabezas-Herrera J; Rodríguez-López JN
    Int J Antimicrob Agents; 2006 Dec; 28(6):560-7. PubMed ID: 17046206
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Feasibility of using collagen as the base of the antifungal drug, miconazole.
    Yoshida K; Hirai K; Ara T; Ito M; Wang PL; Igarashi Y
    J Oral Rehabil; 2006 May; 33(5):363-7. PubMed ID: 16629895
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Change in the composition of Candida albicans cells during development of resistance to polyene antibiotics].
    Virina AM; Feĭgin AM; Belousova II; Tereshin IM
    Mikrobiologiia; 1976 JUL-AUG; 45(4):679-84. PubMed ID: 790101
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exposure of the yeast Candida albicans to the anti-neoplastic agent adriamycin increases the tolerance to amphotericin B.
    O'Keeffe J; Doyle S; Kavanagh K
    J Pharm Pharmacol; 2003 Dec; 55(12):1629-33. PubMed ID: 14738588
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Action of miconazole at high concentrations against Candida albicans.
    D'Auria FD; Villa A; Simonetti N
    J Chemother; 1989 Jul; 1(4 Suppl):240-2. PubMed ID: 16312385
    [No Abstract]   [Full Text] [Related]  

  • 36. [Cytological study of the action of imidazoles on Candida albicans (author's transl)].
    Bastide M; Jouvert S; Bastide JM
    Pathol Biol (Paris); 1982 Jun; 30(6):458-62. PubMed ID: 7050853
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decreased permeability of glycerol in an ergosterol-less mutant of Candida albicans.
    Pesti M; Novák R
    Acta Microbiol Hung; 1984; 31(2):81-4. PubMed ID: 6380195
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The expression of genes involved in the ergosterol biosynthesis pathway in Candida albicans and Candida dubliniensis biofilms exposed to fluconazole.
    Borecká-Melkusová S; Moran GP; Sullivan DJ; Kucharíková S; Chorvát D; Bujdáková H
    Mycoses; 2009 Mar; 52(2):118-28. PubMed ID: 18627475
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modulatory effect of cAMP on fungal ergosterol level and inhibitory activity of azole drugs.
    Sardari S; Mori Y; Kurosawa T; Daneshtalab M
    Can J Microbiol; 2003 May; 49(5):344-9. PubMed ID: 12897828
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship between cell morphology and intracellular potassium concentration in Candida albicans.
    Watanabe H; Azuma M; Igarashi K; Ooshima H
    J Antibiot (Tokyo); 2006 May; 59(5):281-7. PubMed ID: 16883777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.